Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Fabrizio Cantini, Carlotta Nannini, Laura NiccoliSecond Division of Medicine, Rheumatology Unit, Hospital of Prato, ItalyAbstract: Immunologic research has clarified many aspects of the pathogenesis of inflammatory rheumatic disorders. Biologic drugs acting on different steps of the immune response,...
Saved in:
Main Authors: | Fabrizio Cantini, Carlotta Nannini, Laura Niccoli |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/60de55b263df4f9e9a0ff39df114e8dc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
by: Peter BB Jones, et al.
Published: (2010) -
Management of ankylosing spondylitis with infliximab
by: Éric Toussirot, et al.
Published: (2009) -
Efficacy and safety of adalimumab in ankylosing spondylitis
by: Mounach A, et al.
Published: (2014) -
Optimal management of dactylitis in patients with psoriatic arthritis
by: Yamamoto T
Published: (2015) -
Rheumatoid arthritis: Disease or syndrome?
by: Jessica A Stanich, et al.
Published: (2009)